David (Wei Fu) Li
Lawyers
Filters
Ayala Pharmaceuticals $20 million at-the-market offering
We advised the sales agent on the stock offering
Canada $3.5 billion global bond offering
We advised the underwriters on the investment-grade debt offering
Masco $1.5 billion notes offering
We advised the underwriters on the investment-grade debt offering
InflaRx $75 million follow-on offering
We advised the underwriters on the equity offering
Ayala Pharmaceuticals $25 million private placement
We advised the placement agent on the private placement of stock and warrants
Applied Genetic Technologies follow-on offering
We advised the underwriters on the equity offering
American Well $356.8 million secondary offering
We advised Amwell on the stock offering
Northern Genesis Acquisition II $414 million IPO
We advised the underwriters on the SPAC IPO and NYSE listing
Consonance-HFW Acquisition $80 million IPO
Davis Polk advised the sole book-running manager in connection with the $80 million initial public offering of 8,000,000 units of Consonance-HFW Acquisition Corp. Each unit consists of…
BioNTech $500 million SEC-registered at-the-market offering
Davis Polk advised the sales agents in connection with an SEC-registered at-the-market offering by BioNTech SE of its ordinary shares represented by American depositary shares for up to an…